BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 13, 2026
Home
»
Newsletters
» BioWorld
BioWorld
July 11, 2011
View Archived Issues
BioLineRx Trades IPO for ADR To Access Investors, Partners
Read More
New Fentanyl Approvals Hint At Track for Class-Wide REMS
Read More
Money Raised By Biotech in 2011
Read More
Week in Review
Read More
Word on the Street
Read More
FDA Approvals in June
Read More
Phase I Clinical Trials Update: June 2011
Read More
Phase II Clinical Trials Update: June 2011
Read More
Phase III Clinical Trials Update: June 2011
Read More
American Diabetes Association
Read More
American Society of Clinical Oncology
Read More
Public Biotechs Drive Funding Increase in H1 2011 v. H1 2010
Biotech companies raised a total of $13.3 billion in the first half of 2011, reclaiming much of the fundraising ground that was lost when the markets crashed in 2008.
Read More
Money Raised Year to Date
Read More
Non-U.S. Clinical Trials & Regulatory Actions: June 2011
Read More
FDA Submissions, Approvals & Other Actions: June 2011
Read More
Stock Gainers and Losers For The Week
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
